Search Results

There are 2602 results for: content related to: Valproate: Clinical Pharmacological Profile

  1. Bioavailability of divalproex extended-release formulation relative to the divalproex delayed-release formulation

    Biopharmaceutics & Drug Disposition

    Volume 25, Issue 8, November 2004, Pages: 345–352, Sandeep Dutta and Yiming Zhang

    Version of Record online : 17 SEP 2004, DOI: 10.1002/bdd.420

  2. MAINTENANCE TREATMENT WITH QUETIAPINE WHEN COMBINED WITH EITHER LITHIUM OR DIVALPROEX IN BIPOLAR I DISORDER: ANALYSIS OF TWO LARGE RANDOMIZED, PLACEBO-CONTROLLED TRIALS

    Depression and Anxiety

    Volume 30, Issue 11, November 2013, Pages: 1089–1098, Trisha Suppes, Eduard Vieta, Urban Gustafsson and Birgit Ekholm

    Version of Record online : 12 JUN 2013, DOI: 10.1002/da.22136

  3. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009

    Bipolar Disorders

    Volume 11, Issue 3, May 2009, Pages: 225–255, Lakshmi N Yatham, a Sidney H Kennedy, b Ayal Schaffer, b Sagar V Parikh, b Serge Beaulieu, c Claire O'Donovan, d Glenda MacQueen, e Roger S McIntyre, b Verinder Sharma, f Arun Ravindran, b L Trevor Young, a Allan H Young, a Martin Alda, d Roumen Milev, g Eduard Vieta, h Joseph R Calabrese, i Michael Berk, j Kyooseob Ha and k Flávio Kapczinski l

    Version of Record online : 14 APR 2009, DOI: 10.1111/j.1399-5618.2009.00672.x

  4. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013

    Bipolar Disorders

    Volume 15, Issue 1, February 2013, Pages: 1–44, Lakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, Ayal Schaffer, Serge Beaulieu, Martin Alda, Claire O’Donovan, Glenda MacQueen, Roger S McIntyre, Verinder Sharma, Arun Ravindran, L Trevor Young, Roumen Milev, David J Bond, Benicio N Frey, Benjamin I Goldstein, Beny Lafer, Boris Birmaher, Kyooseob Ha, Willem A Nolen and Michael Berk

    Version of Record online : 12 DEC 2012, DOI: 10.1111/bdi.12025

  5. Absolute Bioavailability and Absorption Characteristics of Divalproex Sodium Extended-Release Tablets in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 44, Issue 7, July 2004, Pages: 737–742, Sandeep Dutta, Ronald C. Reed and John H. Cavanaugh

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004266782

  6. Extended-Release Divalproex Sodium for Mood Stabilization

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 9, September 2004, Pages: 1147–1153, Dr. Steven C. Stoner, Dr. Beth M. Dubisar, Dr. Jessica W. Lea, Dr. Patricia A. Marken, Mr Leonard V. Ramlatchman and Dr. James B. Reynolds

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.24.13.1147.38088

  7. Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder

    Bipolar Disorders

    Volume 14, Issue 7, November 2012, Pages: 780–789, David E Kemp, Keming Gao, Elizabeth B Fein, Philip K Chan, Carla Conroy, Sarah Obral, Stephen J Ganocy and Joseph R Calabrese

    Version of Record online : 29 OCT 2012, DOI: 10.1111/bdi.12013

  8. Mood Stabilizers

    Psychiatry, Third Edition

    David J. Muzina, David E. Kemp, Joseph R. Calabrese, Pages: 2202–2222, 2008

    Published Online : 8 AUG 2008, DOI: 10.1002/9780470515167.ch103

  9. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder

    Human Psychopharmacology: Clinical and Experimental

    Volume 22, Issue 7, October 2007, Pages: 469–476, Helen R. Winter, C. Lindsay DeVane, Carlos Figueroa, Debra J. Ennis, Jennifer E. Hamer-Maansson, Patty C. Davis and Mark A. Smith

    Version of Record online : 30 AUG 2007, DOI: 10.1002/hup.869

  10. Safety of Divalproex Sodium in Migraine Prophylaxis: An Open-Label, Long-term Study

    Headache: The Journal of Head and Face Pain

    Volume 39, Issue 9, October 1999, Pages: 633–643, Stephen D. Silberstein, Stephen D. Collins and Long-term Safety of Depakote in Headache Prophylaxis Study Group

    Version of Record online : 17 JUN 2002, DOI: 10.1046/j.1526-4610.1999.3909633.x

  11. Divalproex Sodium in Alcohol Withdrawal: A Randomized Double-Blind Placebo-Controlled Clinical Trial

    Alcoholism: Clinical and Experimental Research

    Volume 25, Issue 9, September 2001, Pages: 1324–1329, Joseph P. Reoux, Andrew J. Saxon, Carol A. Malte, John S. Baer and Kevin L. Sloan

    Version of Record online : 11 APR 2006, DOI: 10.1111/j.1530-0277.2001.tb02354.x

  12. Comparison of the bioavailability of 250 and 500 mg divalproex sodium extended-release tablets in healthy volunteers

    Biopharmaceutics & Drug Disposition

    Volume 25, Issue 8, November 2004, Pages: 353–357, Sandeep Dutta, Yiming Zhang, Lillian L. Lee and Robert O'Dea

    Version of Record online : 17 SEP 2004, DOI: 10.1002/bdd.421

  13. Divalproex for the treatment of geriatric bipolar disorder

    International Journal of Geriatric Psychiatry

    Volume 14, Issue 6, June 1999, Pages: 494–496, Donald J. Mordecai, Javaid I. Sheikh and Ira D. Glick

    Version of Record online : 10 JUN 1999, DOI: 10.1002/(SICI)1099-1166(199906)14:6<494::AID-GPS964>3.0.CO;2-9

  14. Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials

    Bipolar Disorders

    Volume 12, Issue 2, March 2010, Pages: 116–141, Christoph U Correll, Eva M Sheridan and Melissa P DelBello

    Version of Record online : 25 MAR 2010, DOI: 10.1111/j.1399-5618.2010.00798.x

  15. Effects of divalproex sodium on amitriptyline and nortriptyline pharmacokinetics

    Clinical Pharmacology & Therapeutics

    Volume 60, Issue 1, July 1996, Pages: 48–53, Shekman L. Wong, John Cavanaugh, Harry Shi, Walid M. Awni and G. Richard Granneman

    Version of Record online : 1 JUL 1996, DOI: 10.1016/S0009-9236(96)90166-6

  16. A Multiphasic Absorption Model Best Characterizes Gastrointestinal Absorption of Divalproex Sodium Extended-Release Tablets

    The Journal of Clinical Pharmacology

    Volume 46, Issue 8, August 2006, Pages: 952–957, Sandeep Dutta and Ronald C. Reed

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006289480

  17. Valproate: Clinical Pharmacological Profile

    Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition

    Charles L. Bowden, Vivek Singh, Pages: 25–43, 2011

    Published Online : 13 APR 2011, DOI: 10.1002/9780470975114.ch3

  18. Naturalistic experience with the use of divalproex sodium on an in-patient unit for adolescent psychiatric patients

    Acta Psychiatrica Scandinavica

    Volume 97, Issue 3, March 1998, Pages: 236–240, J. A. Deltito, J. Levitan, J. Damore, F. Hajal and M. Zambenedetti

    Version of Record online : 13 NOV 2007, DOI: 10.1111/j.1600-0447.1998.tb09994.x

  19. Acute Seizures in a Patient Receiving Divalproex Sodium After Starting Ertapenem Therapy

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 8, August 2007, Pages: 1202–1205, Jesse L. Lunde, Robert E. Nelson and Harrison F. Storandt

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.8.1202

  20. Posters

    Bipolar Disorders

    Volume 7, Issue s2, June 2005, Pages: 27–117,

    Version of Record online : 2 JUN 2005, DOI: 10.1111/j.1399-5618.2005.00226.x